tbuckley/cabot-search huggingface dataset:
Error-Corrected Next-Generation Sequencing Provides a Comprehensive Overview of the Subclonal Mutation Landscape and Its Prognostic Implications in Juvenile Myelomonocytic Leukemia
Authors: Daichi Sajiki, Manabu Wakamatsu, Hideki Muramatsu, Yusuke Tsumura, Daiki Yamashita, Ryo Maemura, Ayako Yamamori, Kotaro Narita, Shinsuke Kataoka, Atsushi Narita, Noriko Shimasaki, Nobuhiro Nishio, Yoshiyuki Takahashi
Journal: Blood (2023)
Lower-Initiating Dose of Bosutinib for Resistant or Intolerant to Prior Therapy Chronic Myeloid Leukemia Patients (BOGI trial): A Single-Arm, Multicenter, Phase II Trial
Authors: Hiroshi Ureshino, Naoto Takahashi, Takayuki Ikezoe, Ayako Takamori, Atsushi Kawaguchi, Tatsuo Ichinohe, Shinya Kimura
Journal: Blood (2023)
CD22 TCR-Engineered T Cells Exert Anti-Leukemia Cytotoxicity without Causing Inflammatory Responses
Authors: Kazusa Ishii, Zhihui Liu, John S Davies, Kilyna A Nguyen, Crystal P McIntosh, Tejas Kadakia, Scott M Norberg, Zachary Rae, Sooraj Achar, Gregoire Altan-Bonnet, Xiaolin Wu, Michael C Kelly, Naomi Taylor, Christian S Hinrichs
Journal: Blood (2023)
Initial Results of a Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Prevent Relapse after Allogeneic Hematopoietic Cell Transplantation
Authors: Monzr M. Al Malki, Alla Keyzner, Hyung Chan Suh, Aasiya Matin, Erica Buonomo, Yun Wang, Nina Abelowitz, Jim Murray, Gavin Macbeath, Debora Barton, Shrikanta Chattopadhyay, Ran Reshef
Journal: Blood (2023)
Toxicity, Progression-Free Survival, and Quality of Life of Patients Treated with Zanubrutinib Versus Ibrutinib: A Q-TWiST Analysis from the ALPINE Study in Relapsed or Refractory Chronic Lymphocytic Leukemia
Authors: Vincent Levy, Tushar Srivastava, Keri Yang, Palash Purkayastha, Raju Gautam, Kaijun Wang, Leyla Mohseninejad
Journal: Blood (2023)
Small-Molecule U2 Auxiliary Factor Homology Motif (UHM) Domain Inhibitors Cause Splicing Pattern Changes in <i>U2AF1</i> Mutant Leukemia Cells and Induce Sub-G1 Cell Cycle Arrest
Authors: Chao-Yie Yang, Xinrui Yuan, Mona Kazemi Sabzvar, Arda Durmaz, Krishnapriya Chinnaswamy, Jeanne Stuckey, Seth J Corey, Jaroslaw P. Maciejewski, Valeria Visconte
Journal: Blood (2023)
Treatment Outcomes in Unfit Patients with Newly Acute Myeloid Leukemia According to IDH1 Mutational Status: Real World Evidence from the Pethema Epidemiologic Registry
Authors: David Martinez-Cuadron, Blanca Boluda, Jesús Lorenzo Algarra, Juan Miguel Bergua Burgues, Rebeca Rodriguez Veiga, Pilar Martinez Sanchez, Josefina Serrano, Fernando Jesús Ramos-Ortega, Jose A. Pérez-Simón, Mar Tormo, Jose Luis Lopez Lorenzo, Esperanza Lavilla, Teresa Bernal Del Castillo, Carlos Rodríguez-Medina, Maria Carmen GARCIA Garay, Maria Jose Sayas Lloris, Cristina Gil, Maria Teresa Olave Rubio, Raimundo Garcia Boyero, Susana Vives, Maria Angeles Foncillas, Jorge Labrador, Francisco Ibañez, Ana Cabello, Pilar Herrera Puente, Bernardo Javier González González, Eva Barragán, Claudia Sargas, Rosa Ayala, Carmen Chillon, Pau Montesinos
Journal: Blood (2023)
Selective PI3Kδ Inhibitor Parsaclisib Combined with HDAC Inhibitor Chidamide in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Preliminary Results of a Phase Ib/Ⅱ Study
Authors: Zheng Yan, Shuna Yao, Shuang Zhao, Haiying Wang, Junfeng Chu, Yuanlin Xu, Jiuyang Zhang, Lina Zhang, Quande Lin, Lijie Liang, Ping Wang, Wenyong Li, Xiaolu Teng, Zhihua Yao, Yanyan Liu
Journal: Blood (2023)
An International Multicenter Study of Primary Vitreoretinal Lymphoma from the Australasian Lymphoma Alliance and Collaborators
Authors: Catherine Tang, Lucy Zhang, Adam Suleman, Katharine L. Lewis, Daire Quinn, Michelle Poon, William Hann, Edward Pringle, Svetlana Cherepanoff, Luke Coyle, Shireen Kassam, Pam McKay, Chan Yoon Cheah, Anca Prica, Jeffery Smith, Nada Hamad
Journal: Blood (2023)
Venous Thromboembolism in Adolescents and Young Adults with Acute Lymphoblastic Leukemia Treated on a Pediatric-Inspired Regimen
Authors: Hari S. Raman, Shai Shimony, Yannis K. Valtis, Yael Flamand, Andrew E. Place, Lewis B. Silverman, Stephen E. Sallan, Lynda M. Vrooman, Andrew M. Brunner, Donna S. Neuberg, Ilene Galinsky, Jacqueline S. Garcia, Eric S. Winer, Martha Wadleigh, Richard M Stone, Jean M. Connors, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood (2023)
Comparative Effectiveness of Axicabtagene Ciloleucel Vs Historical Standard-of-Care in Patients with Relapsed or Refractory Follicular Lymphoma: An Analysis of CIBMTR and SCHOLAR-5 Data
Authors: Swetha Kambhampati, Hai-Lin Wang, Jiali Yan, Alex F. Herrera, Matthew J. Frank, Leslie L. Popplewell, Nausheen Ahmed, Yi Lin, Frederick L. Locke, Paola Ghione, John G. Gribben, Timothy Best, Christine Fu, Sara Beygi, Markqayne D Ray, John Bian, Zhen-Huan Hu, Fang Sun, Marcelo Pasquini, Caron A. Jacobson
Journal: Blood (2023)
Emicizumab Prophylaxis in Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Primary Analysis of the HAVEN 7 Study
Authors: Steven Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Víctor Jiménez-Yuste, Flora Peyvandi, Guy Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Tiffany Chang, Michaela Lehle, Markus Niggli, Karin Fijnvandraat
Journal: Blood (2023)
Frail and Pre-Frail Older Adults with Acute Myeloid Leukemia Have Inferior Survival Due to Higher Rates of Disease-Related Deaths
Authors: Ashley D Hadjis, Griffin W White, Christopher Catania, Noelle V. Frey, Saar Gill, Elizabeth O Hexner, Ximena Jordan Bruno, Catherine Lai, Andrew H Matthews, Mary Ellen Martin, Daria V Babushok, Alexander Perl, David L. Porter, Alison W Loren, Keith W Pratz, Selina M Luger, Shannon R McCurdy
Journal: Blood (2023)
A Comparative Analysis of Infectious Complications in Patients with Multiple Myeloma Treated with BCMA-Targeted Bispecific Antibodies and CAR T-Cell Therapy
Authors: Karthik Nath, Tala Shekarkhand, Bruno Almeida Costa, David Nemirovsky, Andriy Derkach, Noriko Nishimura, Tasmin Farzana, Colin Rueda, David Chung, Heather Landau, Oscar Boutros Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Kylee H Maclachlan, Neha Korde, Urvi A Shah, Carlyn Rose Tan, Malin Hultcrantz, Sergio A. Giralt, Saad Z Usmani, Zainab Shahid, Sham Mailankody, Alexander Lesokhin
Journal: Blood (2023)
The Impact of Baseline Genetic Profile and Treatment on Hematological Toxicity in <i>CEBPA</i>-Mutated Acute Myeloid Leukemia
Authors: Francesco Mannelli, Matteo Piccini, Marco Frigeni, Giacomo Gianfaldoni, Sara Bencini, Silvia Salmoiraghi, Barbara Scappini, Benedetta Peruzzi, Roberto Caporale, Gaia Ciolli, Laura Fasano, Francesca Crupi, Elisa Quinti, Andrea Pasquini, Sofia Pilerci, Fiorenza Vanderwert, Giada Rotunno, Fabiana Pancani, Leonardo Signori, Danilo Tarantino, Chiara Maccari, Vivian Paradiso, Francesco Annunziato, Orietta Spinelli, Paola Guglielmelli, Alessandro Rambaldi, Alessandro Maria Vannucchi
Journal: Blood (2023)
Measurable Residual Disease Results &amp; Survival with Augmented Early Intensification Therapy in Intermediate-Risk &amp; High-Risk Group Pediatric Acute Lymphoblastic Leukemia Patients Treated with ALL IC-BFM 2009 Protocol: A Single-Center Study from India
Authors: Prof. Uttam Kumar Nath, Karthik Kumar, Adamya Gupta, Reshma Benson, DR Arjun Kachhwaha
Journal: Blood (2023)
Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients
Authors: Guillaume Berton, Bochra Sedaki, Erwann Collomb, Sami Benachour, Michael Loschi, Bilal Mohty, Colombe Saillard, Yosr Hicheri, Camille Rouzaud, Valerio Maisano, Ferdinand Villetard, Evelyne D'Incan Corda, Aude Charbonnier, Jerome Rey, Marie Anne Hospital, Antoine Ittel, Norman Abbou, Raphaelle Fanciullino, Bérengère Dadone-Montaudié, Norbert Vey, Geoffroy Venton, Thomas Cluzeau, Anne Sophie Alary, Sylvain Garciaz
Journal: Blood (2023)
Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma
Authors: Jie Zha, Qinwei Chen, Wei Zhang, Hongmei Jing, Jingjing Ye, Haifeng Yu, Shuhua Yi, Caixia Li, Zhong Zheng, Wei Xu, Zhifeng Li, Lingyan Ping, Xiaohua He, Liling Zhang, Ying Xie, Feili Chen, Xiuhua Sun, Liping Su, Huilai Zhang, Zhijuan Lin, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
Journal: Blood (2023)
<i>Ureaplasma</i>-Induced Hyperammonemia Syndrome - an Acute Complication Post Allogeneic Stem Cell Transplant
Authors: Rohail Badami, Kylie L. Lepic, Dina Khalaf, Alejandro Garcia-Horton, Tobias Berg, Brian Leber, Irwin Walker, Michael Radford
Journal: Blood (2023)
Interpretable Artificial Intelligence (AI) Differentiates Prefibrotic Primary Myelofibrosis (prePMF) from Essential Thrombocythemia (ET): A Multi-Center Study of a New Clinical Decision Support Tool
Authors: Andrew Srisuwananukorn, Giuseppe Gaetano Loscocco, Andrew T. Kuykendall, James M Dolezal, Raffaella Santi, Ling Zhang, Avani M Singh, Paola Guglielmelli, Alessandro Maria Vannucchi, Douglas Tremblay, Alexander T Pearson, Mohamed E. Salama, Ronald Hoffman
Journal: Blood (2023)
Prognostic Utility of the Patient-Derived AML Cells' Ex Vivo Drug Sensitivity Results
Authors: Silvia Park, Sung-Soo Park, Byoung Sik Cho, Sungwon Lim, Kwan Hyun Kim, Gyucheol Choi, Seunghyeok Ham, Seongjoon Lee, Sesun Park, Gunjae Lee, Junyoung Lee, Edward Song, Jamin Koo, Heeje Kim
Journal: Blood (2023)
Introduction of Glofitamab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) after ≥2 Lines of Systemic Therapy Results in Cost Savings to the Healthcare System Based on a United States Budget Impact Analysis
Authors: Zahra Mahmoudjafari, Jia Li, Eric Bercaw, Hélène Parisé, Katalin Bognar, Si-Tien Wang, Anthony Masaquel
Journal: Blood (2023)
A Phase 2, Single-Arm, Non-Inferiority Study of Limited-Duration Teclistamab for Relapsed and Refractory Multiple Myeloma (LimiTec)
Authors: Beatrice Razzo, Connor Grady, Sandra Susanibar-Adaniya, Adam Waxman, Dan T. Vogl, Adam D. Cohen, Edward A. Stadtmauer, Wei-Ting Hwang, Alfred L. Garfall
Journal: Blood (2023)
Phase II Trial of Ibrutinib in Previously Untreated High-Risk Smoldering Mantle Cell Lymphoma
Authors: Charles Gaulin, Preetesh Jain, Ranjit Nair, Swami P. Iyer, Hun Ju Lee, Luis Fayad, Lei Feng, Yang Liu, Holly A Hill, Yijing Li, Chi Young Ok, Rashmi Kanagal-Shamanna, Onyeka Oriabure, Wendy Chen, Asiya Siddiqui, Guofan Xu, Anita Deswal, Cezar Iliescu, Maria Badillo, Shaoying Li, Michelle Ky, Michelle Avellaneda, Guilin Tang, Francisco Vega, Christopher R. Flowers, Michael L. Wang
Journal: Blood (2023)
Efficacy and Safety of Concizumab Prophylaxis in Patients with Hemophilia A or B without Inhibitors: 56-Week Cut-Off Results of the Phase 3 explorer8 Study
Authors: Jan Astermark, Shashikant Apte, Chuhl Joo Lyu, Amalie Rhode Høgh Nielsen, Sonata Saulyte Trakymiene, Jay Jay Thaung Zaw, Huyen Tran, Jerzy Windyga, Hermann Eichler
Journal: Blood (2023)
Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes
Authors: Nicholas J. Boddicker, Raphael Mwangi, Dennis P. Robinson, Cristine Allmer, Allison C. Rosenthal, Thomas M. Habermann, Andrew L. Feldman, Lisa M. Rimsza, Rebecca King, Melissa C. Larson, Brianna Gysbers, Aaron D. Norman, Stephen M Ansell, Angela Dispenzieri, David L Murray, S. Vincent Rajkumar, Shaji Kunnathu Kumar, Jithma Prasad Abeykoon, Grzegorz S. Nowakowski, Thomas E. Witzig, Anne J. Novak, Celine M. Vachon, Susan L. Slager, James R. Cerhan
Journal: Blood (2023)
G-CSF Induces MAIT Cells to Exert Anti-Intestinal Gvhd Effects Dependent on CXCR6 Mediated Chemotaxis
Authors: Gao Mengge, Jun Kong, Yuqian Sun, Zhidong Wang, Ting-Ting Han, Yu Wang, Xiaosu Zhao, Xiao Jun Huang
Journal: Blood (2023)
Developmental Differences between Neonatal and Adult Platelets in Regard to Immune Protein Content and Regulation of Monocyte Inflammatory Responses
Authors: Patricia Ellen Davenport, Christopher S. Thom, Erin L Soule-Albridge, Emily Nolton, Zhi-Jian Liu, Henry A Feldman, Martha Sola-Visner
Journal: Blood (2023)
Allotransplantation and Gene Therapy Equity for Children with Sickle Cell Disease: Distributional Cost-Effectiveness of Allotransplantation Vs Gene Therapy Vs Standard-of-Care in Pediatric Patients with Sickle Cell Disease in the United States
Authors: George Goshua, Satoko Ito, Karthik Chetlapalli, Kunal C Potnis, Cecelia Calhoun, Lakshmanan Krishnamurti, Harlan M. Krumholz, Ankur Pandya
Journal: Blood (2023)
A Prospective Multicenter Phase II Study of Orelabrutinib-Lenalidomide-Rituximab (OLR) in Patients with Untreated Mantle Cell Lymphoma (MCL) in China (POLARIS Study): Preliminary Analysis on Efficacy, Safety, Mutation Spectrum and Impact of Mutation Profiling on Treatment Responses
Authors: Huilai Zhang, Liping Su, Lihong Liu, Ou Bai, Zheng Song, Zhiqiang Zhao, Cuiying He, Qiang Guo, Xianhuo Wang, Wei Li, Lihua Qiu, Lanfang Li, Shiyong Zhou, Yue Fei, Xiaohui Wang, Bin Meng
Journal: Blood (2023)
The Role of Coagulation Gene Polymorphisms in Sars-CoV2 Infection in the Bergamo Area
Authors: Marina Marchetti, Chiara Villa, Sara Gamba, Donatella Conconi, Cinzia Giaccherini, Laura Russo, Silvia Bolognini, Carmen Julia Tartari, Chiara Ticozzi, Cristina Verzeroli, Francesca Schieppati, Luca Barcella, Marialuisa Lavitrano, Anna Falanga
Journal: Blood (2023)
A Prognostic Score Model for Relapsed/Refractory Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Yue Jin, Haixia Fu, Yuhong Chen, Yuanyuan Zhang, Jing-Zhi Wang, Xiao-Dong Mo, Huan Chen, Yao Chen, Yu Wang, Ying-Jun Chang, Lanping Xu, Kai-yan Liu, Xiao-Jun Huang, Xiaohui Zhang
Journal: Blood (2023)
Evaluation of Atrial Fibrillation Risk and Outcome after Allogeneic Transplantation Using an Artificial Intelligence ECG Algorithm and Echocardiographic Parameters in an MDS Cohort
Authors: Mario Ballerini, Michael Heckman, Launia White, Razan Mohty, Yenny Vanegas Moreno, Hassan Alkhateeb, Mohamed A. Kharfan-Dabaja, Nandita Khera, William J. Hogan, Mark R. Litzow, Abhishek A Mangaonkar, Hemant S. Murthy, Jeanne Palmer, Mithun V Shah, Lisa Sproat, Chris Ray, James M. Foran
Journal: Blood (2023)
Safety of CAR-T Cell Therapy in Asymptomatic Patients with Positive Respiratory Viral Testing Prior to CAR-T Infusions
Authors: Reid M. Muenzen, Emeline R. Chong, Dylan Therwhanger, Daniel J. Landsburg, Sunita D. Nasta, Jakub Svoboda, Stefan K. Barta, Mitchell E. Hughes, Elizabeth Weber, Marco Ruella, Noelle V. Frey, David L. Porter, Stephen J. Schuster, Elise A. Chong
Journal: Blood (2023)
NVG-222: A First-in-Class Autoregulating Half-Life Extended ROR1xCD3 T Cell Engager Heralding a New Class of Safer Drugs
Authors: David Granger, Vincent Muczynski, Patricia Henne, Annalisa Baccaro, Dinusha Fernando, Mittal Shah, John Devlin, Kieran O'Donovan, Amit C. Nathwani
Journal: Blood (2023)
Health-Related Quality of Life (HRQoL) in Patients with Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated with Zanubrutinib+ Obinutuzumab Versus Obinutuzumab Monotherapy: The Rosewood Trial
Authors: Judith Trotman, Pier Luigi Zinzani, Yuqin Song, Richard Delarue, Gisoo Barnes, Pil Kim, Elena Ivanova, Boxiong Tang, Jiří Mayer, Ana C. De Oliveira, Sarit Assouline, Christopher R. Flowers
Journal: Blood (2023)
Real-World Response Rates across Lines of Therapy Among Patients with Relapsed/Refractory Follicular Lymphoma
Authors: Tycel Philips, Laurie H. Sehn, Anthony Wang, Junhua Yu, Elizabeth H. Marchlewicz, Rajesh Kamalakar, Kavita Sail, Donald Arnette, Shibing Yang, Alex Mutebi, Fernando Rivas Navarro, Gilles Salles
Journal: Blood (2023)
Phase I Clinical Study of Humanized BCMA-Single-Domain Antibodies-Targeting CAR T (BCMA-CART) in Patients with Relapsed/Refractory Multiple Myeloma
Authors: Gaofeng Zheng, Heng Mei, Gang Ye, Ling Zhou, Cheng Wen, Zhuoxiao Cao, Zhen Cai
Journal: Blood (2023)
The Prognostic Impact of Relative Dose Intensity of Vincristine in R-CHOP for Untreated Patients with Diffuse Large B-Cell Lymphoma: A Supplementary Analysis of JCOG0601
Authors: Takahiro Nakashima, Tomotaka Suzuki, Gakuto Ogawa, Kazuyuki Shimada, Tsutomu Kobayashi, Dai Maruyama, Wataru Munakata, Ken Ohmachi, Tomohiro Kinoshita, Kiyoshi Ando, Hirokazu Nagai
Journal: Blood (2023)
Preclinical Study of DZD8586, a Non-Covalent LYN/BTK Dual Inhibitor with Excellent BBB Penetration, for the Treatment of B-Cell Non-Hodgkin Lymphoma (B-NHL)
Authors: Yu Bai, Ting Wu, Minghui Hu, Sufang Han, Yu Liu, Jie Zheng, Junjun Qin, Lin Zhang, Zhenfan Yang
Journal: Blood (2023)
Response to Subsequent Novel Therapies and Time to Second Progression-Free Survival Event in the MURANO Trial in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Previously Treated with Fixed-Dose Venetoclax Plus Rituximab
Authors: Rosemary Anne Harrup, Arnon P. Kater, Barbara F. Eichhorst, Carolyn Owen, Brenda Chyla, Hyun Yong Jin, Yanwen Jiang, Yi Meng Chang, Rosemary Millen, Marcus Lefebure, Maria Thadani-Mulero, Michelle Boyer, John F. Seymour
Journal: Blood (2023)
Real-World Performance of 2022 Revised World Health Organization (WHO) Criteria for Mixed Phenotype Acute Leukemia (MPAL) B/Myeloid Defined Only By Isolated MPO Expression (isoMPO)
Authors: Alexandra E. Kovach, Sunil S. Raikar, Jemily Malvar, Matthew J. Oberley, Gerald Wertheim, Karen R. Rabin, Jyotinder N. Punia, Alix Seif, Reuven J. Schore, Dragos C. Luca, Terri L. Guinipero, William G. Woods, Viviane Cahen, Yueh-Yun Chi, Maurice R.G. O'Gorman, Brent L. Wood, Etan Orgel
Journal: Blood (2023)
An in Vitro Pilot Study of the Role of Factor IX As an Alternative to Bypassing Agents in the Treatment of Breakthrough Bleeds in Patients with Hemophilia a and Inhibitors Treated with Emicizumab
Authors: Maissaa Janbain, Laurie Josset, Christophe Nougier, Cindy A. Leissinger, Radia Ksayer, Yesim Dargaud
Journal: Blood (2023)
The Use of 2 nd Generation TKIs As First Line Therapy Does Not Prevent CML Related Deaths: Results of an Italian CML Campus Prospective Study in 1277 Patients Treated First Line with Imatinib or 2 nd Generation TKIs
Authors: Valentina Giai, Fabio Stagno, Tiziana Rosso, Fausto Castagnetti, Isabella Capodanno, Massimiliano Bonifacio, Mario Tiribelli, Sara Galimberti, Monica Bocchia, Antonella Gozzini, Giovanni Caocci, Andrea Patriarca, Giuseppe Lanzarone, Anna Guella, Federica Sorà, Luigiana Luciano, Anna Rita Scortechini, Nicola Di Renzo, Pellegrino Musto, Domenico Pastore, Alessandro Maggi, Carmen Fava, Vincenzo Pavone, Claudio Fozza, Giuseppina Spinosa, Angelo Michele Carella, Giuseppe Tarantini, Bruno Martino, Michele Pizzuti, Clara Mannarella, Fabio Saccona, Gianantonio Rosti, Patrizia Pregno, Massimo Breccia, Fabrizio Pane, Giovannino Ciccone, Giorgina Specchia, Giuseppe Saglio
Journal: Blood (2023)
Red Blood Cell Transfusion Independence Status Is an Independent Predictor of Survival: A Post Hoc Time-Dependent Analysis of the Phase 3 Simplify-1, Simplify-2, and Momentum Trials
Authors: Vikas Gupta, Claire N Harrison, Boris Gorsh, Bharat Patel, Zhaohui Wang, Molly Purser, Catherine Ellis, Bryan Strouse, Dwaipayan Patnaik, Jun Kawashima, Ruben A. Mesa
Journal: Blood (2023)
AML Inhibits Lipid Uptake By the Liver through an HGF/c-MET Dependent Mechanism Which Results in an Increased Supply of Free Fatty Acid to the Tumor
Authors: Rebecca S Maynard, Charlotte Hellmich, Katherine Hampton, Dominic Fowler-Shorten, Matthew Markham, Annalisa Altera, Thomas Flint, Ravindu De Silva, Naiara Beraza, Kristian Bowles, Stuart Rushworth
Journal: Blood (2023)
CPX-351 in Patients with Newly Diagnosed Post Myeloproliferative Neoplasms Acute Myeloid Leukemia
Authors: Sylvain Garciaz, Amine Belhabri, Romain Guieze, Laure Goursaud, Pierre Peterlin, Marie-Pierre Ledoux, Hunault-Berger Mathilde, Safia Chebrek, Jean-Baptiste Robin, Arnaud Pigneux, Sarah Bonnet, Caroline Bonmati, Sarah Bertoli, Thorsten Braun, Sylvain Chantepie, Mathieu Meunier, Mael Heiblig, Thomas Cluzeau, Eric Jourdan, Alban Villate, Christian Recher, Norbert Vey, Jerome Rey
Journal: Blood (2023)
A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of Mitapivat in Patients with Sickle Cell Disease: RISE UP Phase 2 Results
Authors: Modupe Idowu, Lucas Otieno, Bogdan Dumitriu, Clarisse LC Lobo, Swee Lay Thein, Biree Andemariam, Obiageli E Nnodu, Adlette Inati, Alexander K Glaros, Sara Teresinha Olalla Saad, Pablo Bartolucci, Raffaella Colombatti, Ali T Taher, Miguel R Abboud, Abdulafeez Oluyadi, Varsha Iyer, Ophelia Yin, Susan Morris, Amber M Yates, Hui Shao, Spurthi Patil, Rolandas Urbstonaitis, Ahmar U Zaidi, Wally R Smith
Journal: Blood (2023)
Venetoclax (VEN) Improves Response Rates but Not Survival in Patients with Chronic Myelomonocytic Leukemia (CMML) Treated with Hypomethylating Agents (HMA): A Multicenter, Propensity Score Analysis
Authors: Douglas Tremblay, Clifford M Csizmar, Courtney D. DiNardo, Somedeb Ball, Noa Rippel, Danielle E. Hammond, Tapan M. Kadia, Farhad Ravandi, Kelly S. Chien, Grace Van Hyfte, Antoine Saliba, Abhishek A Mangaonkar, Terra L Lasho, Aref Al-Kali, Marina Kremyanskaya, Jonathan Feld, Lewis R Silverman, Rami S. Komrokji, John Mascarenhas, Eric Padron, Guillermo Garcia-Manero, David A Sallman, Mrinal M. Patnaik, Guillermo Montalban-Bravo
Journal: Blood (2023)
Assessing Psychosocial Readiness for Gene Therapy in Sickle Cell Disease: A Consensus Statement
Authors: Steven J. Hardy, Lori E. Crosby, Jerlym S. Porter, Soumitri Sil, Cecelia R. Valrie, Charles R. Jonassaint, Shawn M. Bediako, Clayton Andrews, Maria Rivera, Teonna Woolford, Victoria H. Coleman-Cowger
Journal: Blood (2023)
Real-World Tisagenlecleucel Outcomes in Richter-Transformed Chronic Lymphocytic Leukemia: A Center for International Blood &amp; Marrow Transplant Research (CIBMTR) Analysis
Authors: Mazyar Shadman, Matthew J Frigault, Stephen Ronan Foley, Brian T. Hill, Grant Schofield, Caron Jacobson, Samantha M. Jaglowski, Frederick L. Locke, Daniel J. Landsburg, Ron Ram, Peter A Riedell, Gunjan L. Shah, Leslie L. Popplewell, Ranjan Tiwari, Stephen Lim, Harald Jakob Maier, Marta Majdan, Marcelo Pasquini
Journal: Blood (2023)
Longitudinal Patient-Reported Outcomes and Clinical Outcomes By VES-13 and Comprehensive Geriatric Assessment in Older Adults with Aggressive Non-Hodgkin Lymphomas
Authors: Patrick Connor Johnson, Netana Markovitz, Richard Newcomb, Daniel Yang, Julia Rice, Bridget Coffey, Oreofe O. Odejide, Areej El-Jawahri
Journal: Blood (2023)
Assessment of Outcomes of Consolidation Therapy By Number of Cycles of Blinatumomab Received in Newly Diagnosed Measurable Residual Disease Negative Patients with B-Lineage Acute Lymphoblastic Leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial
Authors: Selina M Luger, Zhuoxin Sun, Ryan J Mattison, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang, Janis Racevckis, Hillard M. Lazarus, Jacob M. Rowe, Daniel A. Arber, Matthew J. Wieduwilt, Michaela Liedtke, Julie Bergeron, Brent L. Wood, Yaqi Zhao, Gang Wu, Ti-Cheng Chang, Wenchao Zhang, Keith W Pratz, Shira N. Dinner, Noelle V. Frey, Steven D. Gore, Bhavana Bhatnagar, Ehab L. Atallah, Geoffrey L Uy, Deepa Jeyakumar, Tara L Lin, Cheryl L. Willman, Daniel J. DeAngelo, Elad Sharon, Richard F. Little, Harry P. Erba, Richard M Stone, Charles G. Mullighan, Mark R. Litzow, Martin S. Tallman
Journal: Blood (2023)
Patient-Reported Outcomes of BMT CTN 1703: A Randomized Phase III Study for Gvhd Prophylaxis - a Quality of Life Evaluation
Authors: Shernan G. Holtan, Michael J Martens, Monzr M. Al Malki, Yvonne Efebera, Carrie L. Kitko, Ran Reshef, Andrew R. Rezvani, Brian C. Shaffer, Melhem M. Solh, Janny M. Yao, Lyndsey Runaas, Hany Elmariah, Karilyn T. Larkin, Najla H El Jurdi, Mahasweta Gooptu, Alison W Loren, Aric C. Hall, Amin Alousi, Omer Jamy, William Clark, Leslie Kean, Ami S. Bhatt, Miguel-Angel Perales, Kristy Applegate, Juan WU, Eric Liefer, Nancy DiFronzo, Richard J. Jones, Mary M. Horowitz, Deborah Mattila, Mehdi Hamadani, Javier Bolanos-Meade
Journal: Blood (2023)